Videoconferencing Between Ambulances and Physician Manned Rapid Response Vehicles, Effects on On-site Patient Treatment and Patterns of Referral

December 7, 2015 updated by: Nikolaj Raaber, University of Aarhus

Telemedical Solutions in Medical Emergencies, Advantages and Disadvantages for Patients, Healthcare Professionals, and Healthcare System. Study 3: Videoconferencing Between Ambulances and Physician Manned Rapid Response Vehicles, Effects on On-site Patient Treatment and Pattern of Referral

Physician manned rapid response vehicles are a limited resource in the prehospital handling of acute patients.

In this study mobile videoconferencing between ambulances and the rapid response vehicles enables patient consultation at a distance. Video consultation between patient and the prehospital physician can take place when the patient is at home or in the ambulance.

The primary aim of this study is to examine the effect of video consultation between physician manned rapid response vehicles and patients receiving treatment by ambulance personnel on the number of patients receiving final treatment on-site in the pre-hospital setting

Study Overview

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Horsens, Denmark, 8700
        • Responce A/S
      • Horsens, Denmark, 8700
        • Lægebilen, Hospitalsenheden Horsens

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • All patients receiving prehospital care by ambulance personnel
  • Must receive either telephone or video consultation by physician in rapid response vehicle

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Video consultation
Patients in this arm receive video consultation from physician in doctor manned rapid response vehicle.

iPad air with 4G/3G SIM card is used as device for videoconferencing. LifeSizeClearSea solution is used for videoconferencing.

Video consultation

Other Names:
  • LifeSizeClearSea
Active Comparator: Telephone consultation
Patients receiving prehospital care by ambulance personnel whom receive telephone consultation/supervision by physician in rapid response vehicle.

iPad air with 4G/3G SIM card is used as device for videoconferencing. LifeSizeClearSea solution is used for videoconferencing.

Video consultation

Other Names:
  • LifeSizeClearSea

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Number of patients receiving final treatment on-site prehospitally
Time Frame: Final treatment is registered for the present consultation, expected assesment averagely within 1 hour. Expected to be presented up to 36 months after assessment
Final treatment is registered for the present consultation, expected assesment averagely within 1 hour. Expected to be presented up to 36 months after assessment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Readmission
Time Frame: Within 3 days of primary contact. Will be assessed up to 24 months after primary contact. Expected to be presented up to 36 months after assessment.
For all patients receiving consultation from physician manned rapid response vehicles the number of patients admitted to hospital within 3 days will assessed.
Within 3 days of primary contact. Will be assessed up to 24 months after primary contact. Expected to be presented up to 36 months after assessment.
Change in site of referral
Time Frame: If destination for patient is changed during consultatation with physician it wille be assessed at the end of consultation, expected averagely to be within 1 hour after consultation, expected to presented up to 24 months after primary assessment
If the department to receive the patient is changed during consultation between physician in rapid response vehicle and patient
If destination for patient is changed during consultatation with physician it wille be assessed at the end of consultation, expected averagely to be within 1 hour after consultation, expected to presented up to 24 months after primary assessment
Number of treatments delivered by ambulance personnel
Time Frame: The number of treatments delivered by ambulance personnel during consultation with physician in rapid response vehicle. Expected to be assessed averagely within 1 hour of consultation. Expected to be presented up 36 months after primary assessment
The number of treatments delivered by ambulance personnel during consultation with physician in rapid response vehicle. Expected to be assessed averagely within 1 hour of consultation. Expected to be presented up 36 months after primary assessment

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ambulance staff evaluation of usability of equipment
Time Frame: 1 day
Is investigated by the use of survey
1 day
Physicians evaluation of equipment
Time Frame: 1 day
Is investigated by the use of survey
1 day
Patient satisfaction
Time Frame: Within 3 weeks after receiving consultation
Is investigated by telephone survey.
Within 3 weeks after receiving consultation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Nikolaj Raaber, MD, Central Denmark Region
  • Study Director: Erika Christensen, MD, medical director, Central Denmark Region

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2014

Primary Completion (Anticipated)

November 1, 2014

Study Completion (Anticipated)

December 1, 2014

Study Registration Dates

First Submitted

March 12, 2014

First Submitted That Met QC Criteria

March 20, 2014

First Posted (Estimate)

March 21, 2014

Study Record Updates

Last Update Posted (Estimate)

December 8, 2015

Last Update Submitted That Met QC Criteria

December 7, 2015

Last Verified

December 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • NRAA3

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on All Acutely Ill or Injured Patients Receiving Care by Ambulance Personnel

Clinical Trials on iPad air with 4G/3G SIM card

3
Subscribe